Lilac Biosciences Inc., a life sciences company spun out of the Giuliani RNA Center at Brown University, and Soin Neuroscience have announced the publication of a joint clinical review examining how RNA biomarkers might support the assessment and monitoring of neuropathic pain. The article, “New Insight into RNA Biomarkers in Neuropathic Pain: A Clinician and […]
FairJourney Bio (FJBio) has entered a partnership with AbTherx, Inc. to integrate transgenic mouse-based antibody discovery into its existing discovery and engineering workflow. The agreement, announced at the BIO International Convention 2026, gives FJBio access to AbTherx’s Atlas™ Full Human Diversity (FHD) and Common Light Chain (cLC) mouse technologies.
BioMed X, an innovation engine for the pharmaceutical sector, and Boehringer Ingelheim have announced the launch of a new research team within XSeed Labs, the innovation incubator based at Boehringer’s US research and development headquarters in Ridgefield, Connecticut. The initiative extends an existing collaboration between the two organisations and adds a further research strand focused […]
Estonia-based biotechnology company Icosagen has completed a €45 million expansion programme designed to bring therapeutic protein discovery, development and Good Manufacturing Practice (GMP) production together at a single site in Tartu, Estonia. The initiative establishes what the company describes as a continuous pathway from early-stage discovery through to clinical manufacturing of complex protein therapeutics.
Abcam and EpiCypher have announced a partnership intended to improve the reliability of antibodies used in ChIC/CUT&RUN epigenomic profiling, a development that clinical laboratory scientists working in chromatin biology and biomarker research may wish to note. The collaboration brings together Abcam’s antibody characterisation expertise with EpiCypher’s CUTANA™ ChIC/CUT&RUN platform to co-develop and validate reagents for […]
Two new systems, Co-Scientist and Robin, use teams of AI agents to search literature, generate testable hypotheses and even analyse laboratory data. Early results, published in Nature, include drug repurposing candidates validated in cellular assays for leukaemia and eye disease.
BioMed X, a build-to-solve innovation engine for the pharmaceutical sector, has formally launched the BioMed X Innovation Circle, a new initiative designed to bring together leaders from across the life sciences ecosystem. The group was unveiled during the BIO International Convention 2026, held recently in the United States, and marks a further step in the […]
Korean scientists have identified a novel envelope protein from simian retrovirus 2 that outperforms the industry-standard RD114 protein for manufacturing CAR-T and CAR-NK cell therapies. The discovery, published in Nature Communications, boosted viral titres, gene transduction and tumour control in mice, offering a route to more efficient and affordable cancer immunotherapy production.
Dutch toxicology company Toxys has announced the publication of OECD Test Guideline 446A for ToxTracker, its stem cell-based genotoxicity testing platform, marking formal recognition of the assay within international regulatory testing frameworks. The guideline, issued through the OECD Test Guidelines Programme, opens the door to wider use of ToxTracker in chemical, pharmaceutical and consumer product […]
Researchers at Chiba University in Japan have achieved the first total synthesis of bousigonine B and a new synthesis of bisleuconothine A, two highly complex monoterpenoid indole alkaloids (MIAs) with demonstrated anticancer activity. Using an innovative organocatalytic cascade strategy and bioinspired coupling reactions, the team has established a versatile platform that may accelerate the development […]
August 2026
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.